Member
1 Award

Qidni Labs


Qidni Labs is a NATO DIANA company recognized by Fast Company as a 2025 World Changing Idea. The company has developed a portable, nearly waterless hemodialysis system that will make treatment accessible for over 10 million patients every year.

Industries

health-care
health-diagnostics
medical-device

Nr. of Employees

small (1-50)

Qidni Labs

Qidni Labs Inc., 50 Fountain Plaza, Suite 1400, Buffalo, New York, USA 14202

Qidni Labs is currently seeking investment

Qidni Labs is seeking a series-a investment in the range of 1m-5m

All Investment-seeking Members

Awards

Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)

Commercialization of a Portable and Nearly Waterless Hemodialysis System

Funding (ceiling)

$1,035,430.23

Award Year

2025


Patents

Systems and methods of gas removal from a wearable device

2024-04-23 • US-11964090-B2

View Details

Products

Portable dialysis system (device and disposable cartridge consumables)

A miniaturized hemodialysis system designed to perform full treatments using a small number of standard saline bags as consumables, capable of battery operation and remote clinical monitoring.

Expertise Areas

  • Portable hemodialysis system development
  • Dialysate-free dialysis methods
  • Battery-powered medical device design
  • Remote patient monitoring for dialysis
  • Show More (2)

Key Technologies

  • Hemodialysis
  • Dialysate-free treatment using saline
  • Battery-powered medical devices
  • Miniaturized medical device engineering
  • Show More (1)

Key People

Dr. Morteza Ahmadi

CEO

LinkedIn

News & Updates

Clinical Study Recruitment

Qidni Labs is seeking volunteers currently on hemodialysis to participate in a clinical study in Ontario, Canada, where selected volunteers will receive one session of hemodialysis using the Qidni device.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.